SFS
DCPH

Sowell Financial Services’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Sowell Financial Services’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,991
Closed -$69K – 2903
2021
Q1 		$69K Sell
1,991
-1
-0.1% -$47 ﹤0.01% 1521
2020
Q4 		$114K Buy
1,992
+295
+17% +$17.5K ﹤0.01% 1105
2020
Q3 		$87K Sell
1,697
-1,011
-37% -$49.5K ﹤0.01% 1022
2020
Q2 		$162K Buy
2,708
+2,553
+1,647% +$137K 0.01% 798
2020
Q1 		$6K Sell
155
-882
-85% -$49K ﹤0.01% 1794
2019
Q4 		$65K Buy
+1,037
New +$49.3K 0.01% 1062

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Sowell Financial Services's DCPH Position: Q2 2021 in Review

Sowell Financial Services sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2021, closing a stake of 1,991 shares — an estimated $69K sold.

Sowell Financial Services first reported a position in DCPH in Q4 2019 and held it in 6 quarters. The position peaked at $162K in Q2 2020. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

  • Sowell Financial Services reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,991 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $69K.
  • Sowell Financial Services first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
  • Sowell Financial Services's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $162K in Q2 2020.
  • 147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.